FR2812875B1 - Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation - Google Patents
Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparationInfo
- Publication number
- FR2812875B1 FR2812875B1 FR0010427A FR0010427A FR2812875B1 FR 2812875 B1 FR2812875 B1 FR 2812875B1 FR 0010427 A FR0010427 A FR 0010427A FR 0010427 A FR0010427 A FR 0010427A FR 2812875 B1 FR2812875 B1 FR 2812875B1
- Authority
- FR
- France
- Prior art keywords
- casr
- preparation
- modulating activity
- novel diamines
- diamines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/36—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing at least two amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/26—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0010427A FR2812875B1 (fr) | 2000-08-08 | 2000-08-08 | Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation |
EP20010963065 EP1409453A1 (fr) | 2000-08-08 | 2001-08-07 | Diamines possedant une activite modulatrice des casr |
PCT/FR2001/002562 WO2002012181A1 (fr) | 2000-08-08 | 2001-08-07 | Nouvelles diamines possedant une activite modulatrice des casr |
AU2001284113A AU2001284113A1 (en) | 2000-08-08 | 2001-08-07 | Novel diamines having a casr modulating activity |
US10/344,146 US7157498B2 (en) | 2000-08-08 | 2001-08-07 | Diamines having a CaSR modulating activity |
JP2002518159A JP4896350B2 (ja) | 2000-08-08 | 2001-08-07 | Casr調節活性を有する新規ジアミン |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0010427A FR2812875B1 (fr) | 2000-08-08 | 2000-08-08 | Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2812875A1 FR2812875A1 (fr) | 2002-02-15 |
FR2812875B1 true FR2812875B1 (fr) | 2003-12-12 |
Family
ID=8853394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0010427A Expired - Fee Related FR2812875B1 (fr) | 2000-08-08 | 2000-08-08 | Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation |
Country Status (6)
Country | Link |
---|---|
US (1) | US7157498B2 (fr) |
EP (1) | EP1409453A1 (fr) |
JP (1) | JP4896350B2 (fr) |
AU (1) | AU2001284113A1 (fr) |
FR (1) | FR2812875B1 (fr) |
WO (1) | WO2002012181A1 (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8362274B2 (en) * | 2004-05-28 | 2013-01-29 | Mitsubishi Tanabe Pharma Corporation | Arylalkylamine compound and process for preparing the same |
US7361789B1 (en) | 2004-07-28 | 2008-04-22 | Amgen Inc. | Dihydronaphthalene compounds, compositions, uses thereof, and methods for synthesis |
FR2885129B1 (fr) * | 2005-04-29 | 2007-06-15 | Proskelia Sas | Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation. |
WO2007060026A1 (fr) * | 2005-11-25 | 2007-05-31 | Galapagos Sas | Dérivés de l'urée utiles comme modulateurs des récepteurs du calcium |
WO2007124465A2 (fr) * | 2006-04-20 | 2007-11-01 | Amgen Inc. | Formules d'émulsions stables |
JP5470653B2 (ja) * | 2006-10-26 | 2014-04-16 | アムジエン・インコーポレーテツド | カルシウム受容体調節剤 |
ES2449340T3 (es) | 2007-03-30 | 2014-03-19 | Amgen Inc. | Compuestos calcimiméticos para su uso en el tratamiento de trastornos intestinales |
ES2476391T3 (es) * | 2007-10-15 | 2014-07-14 | Amgen Inc. | Agentes moduladores de receptor de calcio |
US8791147B2 (en) * | 2008-10-08 | 2014-07-29 | Amgen Inc. | Calcium receptor modulating agents |
WO2010104882A1 (fr) | 2009-03-10 | 2010-09-16 | Amgen Inc. | Procédés de modulation de la motilité des spermatozoïdes |
US8765676B2 (en) | 2009-05-27 | 2014-07-01 | Leo Pharma A/S | Calcium sensing receptor modulating compounds and pharmaceutical use thereof |
EP2435400A2 (fr) | 2009-05-27 | 2012-04-04 | Leo Pharma A/S | Composés inédits modulant les récepteurs du calcium et leur utilisation pharmaceutique |
CN102958908A (zh) | 2010-06-30 | 2013-03-06 | 利奥制药有限公司 | 钙敏感受体激动化合物的新多晶型 |
JP5968880B2 (ja) | 2010-06-30 | 2016-08-10 | レオ ファーマ アクティーゼルスカブ | カルシウム模倣化合物の新規多形 |
RU2013128968A (ru) | 2010-11-26 | 2015-01-10 | Лео Фарма А/С | Соединения, активные в отношении кальций-чувствительного рецептора |
JP2014500882A (ja) | 2010-11-26 | 2014-01-16 | レオ ファーマ アクティーゼルスカブ | カルシウム感知受容体活性化合物 |
JP2014508104A (ja) | 2010-11-26 | 2014-04-03 | レオ ファーマ アクティーゼルスカブ | カルシウム感知受容体活性化合物 |
US20130245084A1 (en) | 2010-11-26 | 2013-09-19 | Leo Pharma A/S | Calcium-sensing receptor-active compounds |
CA2828415A1 (fr) | 2011-03-10 | 2012-09-13 | Lupin Limited | Morpholines substituees en tant que modulateurs pour le recepteur de calcium |
WO2012127385A1 (fr) | 2011-03-18 | 2012-09-27 | Lupin Limited | Dérivés benzo[b][1,4]oxazine en tant que modulateurs de récepteurs de détection de calcium |
RS59172B1 (sr) | 2012-02-24 | 2019-10-31 | Lupin Ltd | Supstituisana jedinjenja hromana kao modulatori receptora osetljivog na kalcijum |
WO2013136288A1 (fr) | 2012-03-16 | 2013-09-19 | Lupin Limited | Composés de type 3,4-dihydro-2h-benzo[b] [1,4]oxazine substituée utilisés en tant que modulateurs des récepteurs sensibles au calcium |
WO2014033604A1 (fr) | 2012-08-27 | 2014-03-06 | Lupin Limited | Composés d'arylalkylamine jouant le rôle de modulateurs des récepteurs sensibles au calcium |
GB201217330D0 (en) | 2012-09-28 | 2012-11-14 | Univ Cardiff | Therapeutic for treating inflammatory lung disorders |
TW201602062A (zh) | 2013-08-12 | 2016-01-16 | 魯賓有限公司 | 取代聯苯基化合物作為鈣敏感受體調節劑 |
US9493396B2 (en) | 2013-08-28 | 2016-11-15 | Lupin Atlantis Holdings Sa | Substituted naphthalene compounds as calcium sensing receptor modulators |
WO2015162538A1 (fr) | 2014-04-21 | 2015-10-29 | Lupin Limited | Composés hétérocycliques en tant que modulateurs des récepteurs de détection du calcium pour le traitement de l'hyperparathyroïdie, de l'insuffisance rénale chronique et de la néphropathie chronique |
WO2017037616A1 (fr) | 2015-08-31 | 2017-03-09 | Lupin Limited | Composés d'arylalkylamine comme modulateurs des récepteurs sensibles au calcium |
JP2023512754A (ja) | 2019-12-27 | 2023-03-29 | ルピン・リミテッド | CaSRモジュレーターの医薬組成物ならびにその方法および使用 |
JP2023512918A (ja) | 2020-01-17 | 2023-03-30 | ルピン・リミテッド | クロマン化合物を調製するための方法、プロセスおよび中間体 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3262977A (en) * | 1962-03-10 | 1966-07-26 | Chinoin Gyogyszer Es Vegyeszet | N-aralkyl-1, 1-diphenyl-propylamine derivatives |
CA2173747C (fr) * | 1991-08-23 | 2006-05-23 | Edward F. Nemeth | Arylalkylamines agissant sur les recepteurs du calcium |
DK1281702T3 (da) * | 1991-08-23 | 2006-04-18 | Nps Pharma Inc | Calciumreceptoraktive molekyler |
EA002984B1 (ru) | 1996-04-09 | 2002-12-26 | Эн Пи Эс Фармасьютикалз, Инк. | Кальцилитические соединения, фармацевтические композиции и способ скрининга кальцилитических соединений |
EP0907631B1 (fr) * | 1996-05-01 | 2003-06-18 | Nps Pharmaceuticals, Inc. | Composes servant a declencher l'activite d'un recepteur d'ions inorganiques |
CA2285556A1 (fr) | 1997-04-04 | 1998-10-15 | Smithkline Beecham Corporation | Composes calcilytiques |
UY24949A1 (es) | 1997-04-08 | 2001-04-30 | Smithkline Beecham Corp | Compuestos calcilíticos |
AR014975A1 (es) | 1998-04-08 | 2001-04-11 | Nps Pharma Inc | Compuestos calciliticos, una composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de un medicamento |
MY121054A (en) | 1998-04-08 | 2005-12-30 | Smithkline Beecham Corp | Calcilytic compounds as calcium receptor antagonists. |
-
2000
- 2000-08-08 FR FR0010427A patent/FR2812875B1/fr not_active Expired - Fee Related
-
2001
- 2001-08-07 WO PCT/FR2001/002562 patent/WO2002012181A1/fr active Application Filing
- 2001-08-07 US US10/344,146 patent/US7157498B2/en not_active Expired - Fee Related
- 2001-08-07 AU AU2001284113A patent/AU2001284113A1/en not_active Abandoned
- 2001-08-07 JP JP2002518159A patent/JP4896350B2/ja not_active Expired - Fee Related
- 2001-08-07 EP EP20010963065 patent/EP1409453A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20050192317A1 (en) | 2005-09-01 |
JP4896350B2 (ja) | 2012-03-14 |
AU2001284113A1 (en) | 2002-02-18 |
FR2812875A1 (fr) | 2002-02-15 |
JP2004505949A (ja) | 2004-02-26 |
WO2002012181A1 (fr) | 2002-02-14 |
US7157498B2 (en) | 2007-01-02 |
EP1409453A1 (fr) | 2004-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2812875B1 (fr) | Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation | |
ATE411332T1 (de) | 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden | |
FR12C0012I2 (fr) | Combinaisons d'herbicides et de phytoprotecteurs | |
ATE323661T1 (de) | Behandlung von mineralischen stoffen | |
DE69934877D1 (de) | Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen | |
ID30590A (id) | Celana sekali pakai jenis-celana pendek | |
NO20005265D0 (no) | Substituerte benzamider, deres fremstilling og anvendelse som inhibitorer av cystin-proteaser | |
DE60131797D1 (de) | Spielsystem und entsprechendes computerlesbares Aufzeichungsmedium | |
NO20014966D0 (no) | Fremstilling av biologisk aktive molekyler | |
DE60013021D1 (de) | Herstellung von S,S und R,S Aminosäuren-Isosteren | |
DE60036093D1 (de) | Antagonisten des gardos-kanals | |
FR2816843B1 (fr) | Inhibiteurs de l'enzyme 5 alpha-reductase | |
ID30226A (id) | Komposisi penat rambut | |
DE60120291D1 (de) | Endoskop und Endoskopkapsel | |
DE60104791D1 (de) | Cyclobutendion-Derivate zur Behandlung von Artherosclerose | |
DE60142051D1 (de) | Herstellung von perfluorolefinen | |
ATE234617T1 (de) | Verwendung des saredutant und seiner pharmazeutisch akzeptablen salze zur behandlung von schwere depression | |
DE60110970D1 (de) | Herstellung von gemischten Säureanhydriden und Amidverbindungen | |
ATE254929T1 (de) | Oralverabreichbare lösung von prucaloprid | |
DE60110748D1 (de) | Behandlung von fluorkohlenstoff-beschickungen | |
DE60217870D1 (de) | Verwendung von 2- 5-(4-fluorphenyl)-3-pyridylmethylaminomethyl-chroman und seiner physiologisch annehmbaren salze | |
DE60007360D1 (de) | Amorphe modifikation von torasemid | |
ATE243197T1 (de) | Kristallformen von osanetant | |
EE04553B1 (et) | 15-llilised 8a- ja 9a-laktaamid ning nende valmistamismeetod | |
DE60121845D1 (de) | Spielsystem und entsprechendes computerlesbares Aufzeichungsmedium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20150430 |